American Journal of Respiratory and Critical Care Medicine

. (2023) Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Annals of the American Thoracic Society 20:12, 1683-1693.
Online publication date: 1-Dec-2023.
First Page | Full Text | PDF (736 KB) | Supplemental Material 
. (2023) ANT1 and the SASP: Beyond the Bioenergetic Void. American Journal of Respiratory Cell and Molecular Biology 69:5, 495-496.
Online publication date: 1-Nov-2023.
First Page | Full Text | PDF (523 KB) | Supplemental Material 
. (2023) To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine 208:9, 949-951.
Online publication date: 1-Nov-2023.
First Page | Full Text | PDF (632 KB) | Supplemental Material 
. (2023) Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds. American Journal of Respiratory and Critical Care Medicine 208:8, 858-867.
Online publication date: 13-Oct-2023.
Abstract | Full Text | PDF (1481 KB) | Supplemental Material 
. (2023) Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis. American Journal of Respiratory and Critical Care Medicine 208:6, 695-708.
Online publication date: 15-Sep-2023.
Abstract | Full Text | PDF (1431 KB) | Supplemental Material 
. (2023) Adult Interstitial Lung Abnormalities: The New Frontier of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 208:6, 651-652.
Online publication date: 15-Sep-2023.
First Page | Full Text | PDF (571 KB) | Supplemental Material 
. (2023) Understanding the Physiological Endotypes Responsible for Comorbid Obstructive Sleep Apnea in Patients with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine 208:5, 624-627.
Online publication date: 1-Sep-2023.
First Page | Full Text | PDF (757 KB) | Supplemental Material 
. (2023) Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine 208:3, 238-246.
Online publication date: 1-Aug-2023.
Abstract | Full Text | PDF (1063 KB) | Supplemental Material 
. (2023) Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.. American Journal of Respiratory and Critical Care Medicine 207:11, 1542-1543.
Online publication date: 1-Jun-2023.
First Page | Full Text | PDF (514 KB) 
. (2023) Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants. American Journal of Respiratory and Critical Care Medicine 207:9, 1118-1120.
Online publication date: 1-May-2023.
First Page | Full Text | PDF (598 KB) | Supplemental Material 
. (2023) Summary for Clinicians: Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults. Annals of the American Thoracic Society 20:5, 632-637.
Online publication date: 1-May-2023.
First Page | Full Text | PDF (713 KB) | Supplemental Material 
. (2023) Interstitial Lung Disease in Veterans: Leveraging Big Data to Bridge Evidence and Practice Gaps. Annals of the American Thoracic Society 20:4, 504-507.
Online publication date: 31-Mar-2023.
First Page | Full Text | PDF (576 KB) | Supplemental Material 
. (2023) Spirometry in 2022: Is a Single Set of Prediction Equations for All the Best Path Forward?. American Journal of Respiratory and Critical Care Medicine 207:6, 659-661.
Online publication date: 15-Mar-2023.
First Page | Full Text | PDF (603 KB) | Supplemental Material 
. (2023) Screening for Preclinical Pulmonary Fibrosis: Are We There Yet?. American Journal of Respiratory and Critical Care Medicine 207:5, 506-508.
Online publication date: 1-Mar-2023.
First Page | Full Text | PDF (588 KB) | Supplemental Material 
. (2023) Functional Criteria to Define Progressive Pulmonary Fibrosis: Searching for the Holy Grail. American Journal of Respiratory and Critical Care Medicine 207:3, 368-369.
Online publication date: 1-Feb-2023.
First Page | Full Text | PDF (570 KB) | Supplemental Material 
. (2023) Reply to Noboa-Sevilla et al.. American Journal of Respiratory and Critical Care Medicine 207:3, 369-370.
Online publication date: 1-Feb-2023.
First Page | Full Text | PDF (571 KB) | Supplemental Material 
PFF Best Practices Committee. (2023) Differences in Patient Outcomes across the Pulmonary Fibrosis Foundation Care Center Network. American Journal of Respiratory and Critical Care Medicine 207:2, 214-218.
Online publication date: 13-Jan-2023.
First Page | Full Text | PDF (604 KB) | Supplemental Material 
. (2023) Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 207:1, 69-76.
Online publication date: 30-Dec-2022.
Abstract | Full Text | PDF (938 KB) | Supplemental Material 
for the Austin ILD Registry and CARE-PF Investigators. (2023) Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions. American Journal of Respiratory and Critical Care Medicine 207:1, 102-105.
Online publication date: 30-Dec-2022.
First Page | Full Text | PDF (689 KB) | Supplemental Material 
. (2023) Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart. American Journal of Respiratory and Critical Care Medicine 207:1, 11-13.
Online publication date: 30-Dec-2022.
First Page | Full Text | PDF (631 KB) | Supplemental Material 
. (2023) Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases. American Journal of Respiratory and Critical Care Medicine 207:1, 9-11.
Online publication date: 30-Dec-2022.
First Page | Full Text | PDF (591 KB) | Supplemental Material 
. (2022) Better to Be an Agnostic than a Believer (at Least in Pulmonary Fibrosis). American Journal of Respiratory and Critical Care Medicine 206:12, 1439-1440.
Online publication date: 15-Dec-2022.
First Page | Full Text | PDF (505 KB) | Supplemental Material 
. (2022) Idiopathic Pulmonary Fibrosis Update: Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?. American Journal of Respiratory and Critical Care Medicine 206:10, 1293-1293.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (563 KB) | Supplemental Material 
. (2022) Reply to Moran-Mendoza: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?. American Journal of Respiratory and Critical Care Medicine 206:10, 1298-1298.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (489 KB) | Supplemental Material 
. (2022) Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?. American Journal of Respiratory and Critical Care Medicine 206:10, 1293-1294.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (621 KB) | Supplemental Material 
. (2022) Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse. American Journal of Respiratory and Critical Care Medicine 206:10, 1294-1295.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (507 KB) | Supplemental Material 
. (2022) Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults. American Journal of Respiratory and Critical Care Medicine 206:10, 1296-1296.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (489 KB) 
. (2022) Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?. American Journal of Respiratory and Critical Care Medicine 206:10, 1297-1297.
Online publication date: 15-Nov-2022.
First Page | Full Text | PDF (457 KB) | Supplemental Material 
. (2022) Reply to Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj. American Journal of Respiratory and Critical Care Medicine 206:7, 919-920.
Online publication date: 30-Sep-2022.
First Page | Full Text | PDF (564 KB) | Supplemental Material 
. (2022) Biomarkers for Interstitial Lung Abnormalities: A Stepping-stone Toward Idiopathic Pulmonary Fibrosis Prevention?. American Journal of Respiratory and Critical Care Medicine 206:3, 244-246.
Online publication date: 1-Aug-2022.
First Page | Full Text | PDF (520 KB) | Supplemental Material 
. (2022) Pirfenidone in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 19:6, 1030-1039.
Online publication date: 1-Jun-2022.
Abstract | Full Text | PDF (680 KB) | Supplemental Material 
. (2022) Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 19:6, 1040-1049.
Online publication date: 1-Jun-2022.
Abstract | Full Text | PDF (674 KB) | Supplemental Material 
. (2022) Antacid Medication and Antireflux Surgery in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 19:5, 833-844.
Online publication date: 29-Apr-2022.
Abstract | Full Text | PDF (743 KB) | Supplemental Material 
. (2022) Use of a Genomic Classifier in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Annals of the American Thoracic Society 19:5, 827-832.
Online publication date: 29-Apr-2022.
Abstract | Full Text | PDF (656 KB) | Supplemental Material 

Related

No related items
Comments Post a Comment




New User Registration

Not Yet Registered?
Benefits of Registration Include:
 •  A Unique User Profile that will allow you to manage your current subscriptions (including online access)
 •  The ability to create favorites lists down to the article level
 •  The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers
American Journal of Respiratory and Critical Care Medicine
205
9

Click to see any corrections or updates and to confirm this is the authentic version of record